{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_52568"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_52568","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"IMAGING AND THERAPY OF OVARIAN CANCER WITH TARGETED RADIOLABELED ANTIBODIES","abstract":"Thesis (Ph.D.)--Michigan State University. Comparative Medicine and Integrative Biology - Doctor of Philosophy, 2025","abstract_html":"Thesis (Ph.D.)--Michigan State University. Comparative Medicine and Integrative Biology - Doctor of Philosophy, 2025","abstract_has_math":false,"creators":["Metebi, Abdullah"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Zinn, Kurt KZ","Jinda, Fan FJ","Spence, Dana DS","Hegg, Colleen CH"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2025,"date_issued":"2025","date_published":"2025","updated_at":"2026-11-18T18:59:06Z","subjects":["Medical imaging","Veterinary science","Veterinary medicine","Diagnostic imaging"],"languages":["eng"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52568","local:Metebi_grad.msu_0128D_21491"],"render_values":[{"text":"etd:52568","href":null,"code":true},{"text":"local:Metebi_grad.msu_0128D_21491","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/5kz9-6j51","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/5kz9-6j51","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_52568","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Zinn, Kurt KZ","Jinda, Fan FJ","Spence, Dana DS","Hegg, Colleen CH"]},{"key":"dc:creator","label":"Author","values":["Metebi, Abdullah"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2025"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["text","Electronic dissertations"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Medical imaging","Veterinary science","Veterinary medicine","Diagnostic imaging"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52568","local:Metebi_grad.msu_0128D_21491","https://doi.org/doi:10.25335/5kz9-6j51"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (Ph.D.)--Michigan State University. Comparative Medicine and Integrative Biology - Doctor of Philosophy, 2025","Ovarian cancer, notorious for its late-stage diagnosis and high mortality rate, poses a significant challenge in oncology. Traditional therapies often fall short, necessitating more effective and targeted treatment modalities. This dissertation delves into the prospective utilization of targeted radiolabeled antibodies for ovarian cancer treatment. The research focuses on Pb-214/Bi-214-TCMC-Trastuzumab and Pb-212-TCMC-hAnnA1, assessing their efficacy in preclinical mouse models. The first section of the thesis demonstrates the inhibitory effect of Pb-214/Bi-214-TCMC-Trastuzumab on human epidermal growth factor receptor positive (HER2-positive) ovarian cancer growth, leveraging the targeted alpha therapy (TAT) approach. The compound's therapeutic potential, biodistribution, and toxicity profile are systematically evaluated, presenting a promising avenue for advanced ovarian cancer treatment. Subsequent chapters introduce the first-in-class humanized Annexin A1 (hAnnA1) antibody, evaluated for its specificity in targeting ovarian cancer cells. The use of this antibody, when conjugated with the alpha-emitting radionuclide Pb-212, shows a substantial reduction in tumor burden, reinforcing the potential of TAT in a clinical setting. This dissertation underscores the complexity of ovarian cancer treatment and presents evidence for the efficacy of novel radiolabeled antibodies in its management. The findings pave the way for future clinical trials and the development of new therapeutic strategies that could offer hope to patients facing this devastating disease. The concluding chapters highlight the necessity for further research, emphasizing combination therapies, personalized medicine, and advancements in radiolabeling techniques. The promising results of Pb-214/Bi-214-TCMC-Trastuzumab and Pb-212-TCMC-hAnnA1 in preclinical models warrant their continued investigation with the goal of improving patient outcomes and expanding treatment options in the realm of ovarian cancer therapy.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf","1 online resource (117 p.) : ill."]},{"key":"dc:title","label":"Title","values":["IMAGING AND THERAPY OF OVARIAN CANCER WITH TARGETED RADIOLABELED ANTIBODIES"]}]}],"canonical_facts":{"dc:contributor":["Zinn, Kurt KZ","Jinda, Fan FJ","Spence, Dana DS","Hegg, Colleen CH"],"dc:creator":["Metebi, Abdullah"],"dc:date":["2025"],"dc:description":["Thesis (Ph.D.)--Michigan State University. Comparative Medicine and Integrative Biology - Doctor of Philosophy, 2025","Ovarian cancer, notorious for its late-stage diagnosis and high mortality rate, poses a significant challenge in oncology. Traditional therapies often fall short, necessitating more effective and targeted treatment modalities. This dissertation delves into the prospective utilization of targeted radiolabeled antibodies for ovarian cancer treatment. The research focuses on Pb-214/Bi-214-TCMC-Trastuzumab and Pb-212-TCMC-hAnnA1, assessing their efficacy in preclinical mouse models. The first section of the thesis demonstrates the inhibitory effect of Pb-214/Bi-214-TCMC-Trastuzumab on human epidermal growth factor receptor positive (HER2-positive) ovarian cancer growth, leveraging the targeted alpha therapy (TAT) approach. The compound's therapeutic potential, biodistribution, and toxicity profile are systematically evaluated, presenting a promising avenue for advanced ovarian cancer treatment. Subsequent chapters introduce the first-in-class humanized Annexin A1 (hAnnA1) antibody, evaluated for its specificity in targeting ovarian cancer cells. The use of this antibody, when conjugated with the alpha-emitting radionuclide Pb-212, shows a substantial reduction in tumor burden, reinforcing the potential of TAT in a clinical setting. This dissertation underscores the complexity of ovarian cancer treatment and presents evidence for the efficacy of novel radiolabeled antibodies in its management. The findings pave the way for future clinical trials and the development of new therapeutic strategies that could offer hope to patients facing this devastating disease. The concluding chapters highlight the necessity for further research, emphasizing combination therapies, personalized medicine, and advancements in radiolabeling techniques. The promising results of Pb-214/Bi-214-TCMC-Trastuzumab and Pb-212-TCMC-hAnnA1 in preclinical models warrant their continued investigation with the goal of improving patient outcomes and expanding treatment options in the realm of ovarian cancer therapy.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."],"dc:format":["application/pdf","1 online resource (117 p.) : ill."],"dc:identifier":["etd:52568","local:Metebi_grad.msu_0128D_21491","https://doi.org/doi:10.25335/5kz9-6j51"],"dc:language":["eng"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["In Copyright"],"dc:subject":["Medical imaging","Veterinary science","Veterinary medicine","Diagnostic imaging"],"dc:title":["IMAGING AND THERAPY OF OVARIAN CANCER WITH TARGETED RADIOLABELED ANTIBODIES"],"dc:type":["text","Electronic dissertations"]},"updated_at":"2026-11-18T18:59:06Z"}